NIPH Clinical Trials Search

Effects of Teneligliptin improvement endotherial dysfunction, inflammation, coagulation and oxidative stress in patients with coronary artery disease and diabetes, pilot study(Tiramisu study).

Basic Information

Recruitment status	Complete: follow-up complete
Health condition(s) or Problem(s) studied	Coronary artery disease
Date of first enrollment	2013/10/05
Target sample size	30
Countries of recruitment	Japan
Study type	Interventional
Intervention(s)	Teneligliptin

Outcome(s)

Primary Outcome	improvement of endothelial function
Secondary Outcome	HbA1c,Glycated albumin,1.5-anhydro-D-glucitol,fasting plasma glucose, immunoreactive insulin, HOMA-IR, HOMA-beta, hs-CRP, IL-6, MCP-1, TNF-alpha Red blood cell, White blood cell, platelet, D dimer, FDP, fibrinogen, 8-OHdG, BNP, body weight

Key inclusion & exclusion criteria

Age minimum	20years-old
Age maximum	Not applicable
Gender	Male and Female
Include criteria
Exclude criteria	Type I diabetes